PolyPid PYPD
NASDAQ PYPD
$5.10 +0.02 (+0.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

PolyPid (PYPD) Long-Term Investments (2019 - 2023)

PolyPid (PYPD) posted Long-Term Investments of $9.3 million for Q4 2023, down 20.99% sequentially from $11.8 million in Q4 2022, and down 20.99% YoY from $11.8 million in Q4 2022.

PolyPid (PYPD) Long-Term Investments (2019 - 2023) Analysis & Trends

PolyPid has reported Long-Term Investments for 5 years, with the latest figure at $9.3 million in Q4 2023.

  • Quarterly Long-Term Investments fell 20.99% year-over-year to $9.3 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $9.3 million (down 20.99% YoY) and the FY2023 annual result came in at $9.3 million, down 20.99% from the prior year.
  • Long-Term Investments slipped to $9.3 million in Q4 2023 per PYPD's latest filing, from $11.8 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $28.6 million in Q4 2020 and troughed at $6.4 million in Q4 2019.
  • A 5-year average of $12.5 million and a median of $9.8 million in 2022 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2020 and 2021: Long-Term Investments jumped 351.06% in 2020, then plunged 67.1% in 2021.
  • Over 5 years, Long-Term Investments stood at $6.4 million in 2019, then surged by 351.06% to $28.6 million in 2020, then slumped by 67.1% to $9.4 million in 2021, then climbed by 24.97% to $11.8 million in 2022, then slipped by 20.99% to $9.3 million in 2023.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $9.3 million, $11.8 million, and $9.8 million for Q4 2023, Q4 2022, and Q2 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.77 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 22.17 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 372.10 Mn
10 PolyPid 113.86 Mn 107.09 Mn - 6.35 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 9.31 Mn
Dec 31, 2022 11.78 Mn
Jun 30, 2022 9.80 Mn
Dec 31, 2021 9.42 Mn
Jun 30, 2021 12.22 Mn
Dec 31, 2020 28.65 Mn
Dec 31, 2019 6.35 Mn